Cure Is Possible: Extensively Metastatic HER2-Positive Gastric Carcinoma with 5 years of Complete Remission after Therapy with the FLOT Regimen and Trastuzumab

In conclusion, Trastuzumab in combination with FLOT may have curative potential even for metastatic stages of HER-2-positive GC.Case Rep Gastroenterol 2022;16:80 –88
Source: Case Reports in Gastroenterology - Category: Gastroenterology Source Type: research